Latest Regulus Therapeutics Inc. Stories
- Interim Results from Ongoing Study Demonstrate Human Proof-of-Concept and Underscore the Value of Regulus' microRNA Platform - LA JOLLA, Calif., Oct.
-New Preclinical Results Increase Mechanistic Understanding of Targeting miR-103/107 for Metabolic Disorders and miR-21 for Renal Dysfunction in Alport Syndrome Patients- LA JOLLA, Calif.,
-Newly Allowed Claims Demonstrate Regulus' Leadership in the microRNA Field- LA JOLLA, Calif., Sept.
-ATHENA to Shed Light on Rare, Life-Threatening Kidney Disease - LA JOLLA, Calif., Sept.
LA JOLLA, Calif., Aug. 7, 2014 /PRNewswire/ -- Regulus Therapeutics Inc.
- 'Clinical Map Initiative' On Track; Human Proof of Concept Results for RG-101 and Nomination of Third Clinical Candidate Expected by YE 2014 - LA JOLLA, Calif., Aug.
LA JOLLA, Calif., July 30, 2014 /PRNewswire/ -- Regulus Therapeutics Inc.
- New Method of Use Claims Strengthen Patent Estate Covering microRNA-122 Inhibitors for the Treatment of HCV Infection - LA JOLLA, Calif., June 25, 2014 /PRNewswire/ --
- Recognized Industry Leader Brings Extensive Clinical and Product Development Expertise - LA JOLLA, Calif., June 16, 2014 /PRNewswire/ --
LA JOLLA, Calif., May 9, 2014 /PRNewswire/ -- Regulus Therapeutics Inc.
- An imitative word; an onomatopoetic word.